Mizuho raises CarMax stock price target on strategic update
Mizuho raised its price target for CarMax (KMX) to $50, citing strategic updates and cost-cutting measures. The stock has surged 45% in six months, currently trading at $53.38. CarMax reported strong Q2 earnings, beating estimates, and received upgrades from BofA and UBS, with new targets of $65 and $62 respectively.
How this was made
The 30-second read
Why it matters
The combination of strong earnings and fresh analyst upgrades may sustain short‑term interest but also invites profit‑taking given the stock's current price above new targets.
Market read
Analyst upgrades provide fresh valuation data for CarMax, a key player in the used‑car market, influencing short‑term trading decisions.
What to watch
Potential headwinds from CarMax Auto Finance and broader macro‑economic pressures on used‑car demand.
Background
CarMax recently reported strong Q2 fiscal 2027 results, beating earnings and revenue expectations, prompting several analysts to raise targets.
Ticker impact
Mizuho raised its price target on CarMax (KMX) to $50 and BofA upgraded the stock to Buy with a $65 target, indicating fresh analyst upgrades and higher valuation expectations.
potential modest downside as the market prices in the higher targets while the stock is already above them
The stock is trading at $53.38, above the new $50 target, so investors may take profits; however, the upgraded ratings could support a rebound if buying interest resumes.
Market effects
The used‑car retail sector may see modest re‑rating as analysts highlight cost‑cutting and growth initiatives at CarMax.
U.S. consumer discretionary sentiment could be slightly lifted by positive coverage of CarMax's turnaround.
Limited to U.S. markets; no broader macro impact.
Counterpoint
Despite upgrades, the stock may be overbought after a 45% rally; a pullback could be imminent.
Key entities
- analystMizuho
Raised CarMax price target to $50, Neutral rating
- analystBofA Securities
Upgraded CarMax to Buy, target $65
- analystUBS
Adjusted target to $62, Neutral rating
